Loading company…
Shanghai-based cellular medical health company developing cell therapies for healthy aging and age-related disease.
Shanghai Cell Therapy Group Co., Ltd. develops cellular rejuvenation products and therapies for healthcare providers and patients, focusing on preventing and intervening in age-related health conditions. Established in 2013 and headquartered in Shanghai, China, and founded by Jiewei Li, it secured CNY 500 million in Series D funding on March 24, 2021, from CCB International, Haier Capital and Jiuzhou Venture. The company sells its therapies through B2B partnerships with healthcare institutions and clinics.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in